Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Atte Riikola

Analyst

Atte Riikola portrait

Coverage

Remedy EntertainmentAdmicomLemonsoftAdministerNokiaQPR SoftwareTelesteCanatuAallon GroupQt GroupF-SecureEasor

Latest content

ShowingAll content types

Is Lemonsoft about to be taken private?

Analyst Comment 02.10.2026 klo 13.00 by Atte Riikola
Lemonsoft

Could Control Resonant be a massive success for Remedy?

Video 28.09.2026 klo 13.56 by Atte Riikola, Tomi Valkeajärvi
Remedy Entertainment

Remedy: Control Resonant seems to be selling well

Research 28.09.2026 klo 10.48 by Atte Riikola
Remedy Entertainment

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account

Teleste receives landmark 40 MEUR order from Siemens

Analyst Comment 25.09.2026 klo 09.30 by Atte Riikola
Teleste

Aallon Group Extensive Report: Acquisition-driven growth amid the AI revolution

Extensive research 22.09.2026 klo 10.32 by Atte Riikola
Aallon Group

Remedy: Control Resonant's success will at least not depend on critic reviews

Analyst Comment 21.09.2026 klo 09.35 by Atte Riikola
Remedy Entertainment

Canatu concludes change negotiations as expected

Analyst Comment 16.09.2026 klo 09.28 by Atte Riikola
Canatu

Remedy's Control Resonant to be launched in three weeks – what to keep an eye on in its lead-up?

Analyst Comment 03.09.2026 klo 10.12 by Atte Riikola
Remedy Entertainment

Canatu H1'26: Growth story takes more hits, long game still alive

Research 26.08.2026 klo 12.15 by Atte Riikola
Canatu

Canatu: Expected new reactor order, outlook disappoints

Analyst Comment 24.08.2026 klo 12.50 by Atte Riikola
Canatu